William Blair Initiates Coverage On Palvella Therapeutics with Outperform Rating

William Blair analyst Alethia Young has initiated coverage on Palvella Therapeutics (NASDAQ: PVLA) with an Outperform rating. This marks a significant endorsement for the company as it seeks to enhance its market presence.